HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Giuseppe Matarese Selected Research

Leptin

9/2015Longitudinal assessment of immuno-metabolic parameters in multiple sclerosis patients during treatment with glatiramer acetate.
1/2015Leptin in autoimmune diseases.
1/2014Leptin enhances availability of apoptotic cell-derived self-antigen in systemic lupus erythematosus.
1/2014Neuro-endocrine networks controlling immune system in health and disease.
4/2013Cutting edge: Leptin-induced RORγt expression in CD4+ T cells promotes Th17 responses in systemic lupus erythematosus.
9/2012Leptin-induced mTOR activation defines a specific molecular and transcriptional signature controlling CD4+ effector T cell responses.
9/2012At the crossroad of T cells, adipose tissue, and diabetes.
3/2012Cutting edge: fasting-induced hypoleptinemia expands functional regulatory T cells in systemic lupus erythematosus.
11/2011"Eczemas" and leptin.
8/2011Leptin administration to overweight and obese subjects for 6 months increases free leptin concentrations but does not alter circulating hormones of the thyroid and IGF axes during weight loss induced by a mild hypocaloric diet.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Giuseppe Matarese Research Topics

Disease

14Obesity
09/2015 - 10/2002
13Multiple Sclerosis
11/2015 - 01/2003
11Inflammation
01/2014 - 11/2003
9Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2014 - 01/2003
7Autoimmune Diseases (Autoimmune Disease)
11/2015 - 05/2002
4Relapsing-Remitting Multiple Sclerosis
09/2015 - 04/2005
4Neoplasms (Cancer)
01/2015 - 06/2010
4Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2014 - 03/2012
4Encephalomyelitis (Myeloencephalitis)
09/2009 - 01/2003
3Disease Progression
07/2013 - 01/2006
3Starvation
09/2012 - 01/2003
3Endometriosis (Adenomyosis)
09/2009 - 05/2003
2Melanoma (Melanoma, Malignant)
01/2014 - 01/2013
2Tuberculosis (Tuberculoses)
02/2013 - 03/2004
2Amenorrhea
02/2013 - 04/2011
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2013 - 05/2006
2Fibrosarcoma
03/2012 - 05/2006
2Weight Loss (Weight Reduction)
08/2011 - 06/2011
2Body Weight (Weight, Body)
06/2011 - 01/2003
2Atherosclerosis
09/2009 - 01/2007
2Infection
10/2008 - 04/2002
1Cardiovascular Diseases (Cardiovascular Disease)
01/2015
1Neuroblastoma
01/2015
1Habitual Abortion (Recurrent Miscarriage)
11/2014
1HIV Infections (HIV Infection)
02/2013
1Skin Neoplasms (Skin Cancer)
01/2013
1Allergic Contact Dermatitis
11/2011
1Eczema
11/2011
1Atopic Dermatitis (Atopic Eczema)
11/2011
1Overweight
08/2011
1Lipodystrophy
06/2011
1Insulin Resistance
05/2011
1Fatty Liver
06/2010
1Fibrosis (Cirrhosis)
06/2010
1Breast Neoplasms (Breast Cancer)
06/2010
1Ovarian Diseases (Ovarian Disease)
09/2009
1Pneumonia (Pneumonitis)
09/2009
1Glomerulonephritis
06/2009
1Anorexia Nervosa
10/2008
1Malnutrition
10/2008
1Mucopolysaccharidosis VI (Syndrome, Maroteaux-Lamy)
01/2008
1Hyperphagia
01/2007
1Hypertrophy
11/2006
1Goiter
11/2006
1Nodular Goiter
11/2006
1Hyperplasia
11/2006
1Liver Diseases (Liver Disease)
01/2006

Drug/Important Bio-Agent (IBA)

37LeptinIBA
09/2015 - 04/2002
5Leptin ReceptorsIBA
09/2015 - 01/2007
4HormonesIBA
01/2014 - 08/2010
4AdipokinesIBA
01/2013 - 01/2007
3Interleukin-2 (IL2)IBA
11/2015 - 04/2002
3AntigensIBA
11/2014 - 03/2004
3metreleptinIBA
02/2013 - 06/2011
2Acute-Phase Proteins (Acute-Phase Protein)IBA
01/2014 - 05/2004
2CytokinesIBA
01/2014 - 05/2003
2recombinant methionyl human leptinIBA
02/2013 - 05/2006
2CannabinoidsIBA
01/2013 - 12/2005
2DNA (Deoxyribonucleic Acid)IBA
01/2013 - 06/2009
2MethylcholanthreneIBA
03/2012 - 05/2006
2Histamine (Histamine Dihydrochloride)FDA Link
02/2011 - 01/2006
2AutoantibodiesIBA
06/2009 - 05/2003
1copolymer 1 (glatiramer acetate)FDA Link
09/2015
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
09/2015
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
09/2015
1CD40 Ligand (CD40L)IBA
09/2015
1Peroxidase (Myeloperoxidase)IBA
09/2015
1OsteoprotegerinIBA
09/2015
1Polychlorinated Biphenyls (PCBs)IBA
01/2015
1Chlorodiphenyl (54% Chlorine)IBA
01/2015
1Interleukin-2 Receptors (IL 2 Receptor)IBA
01/2014
1Interleukin-6 (Interleukin 6)IBA
01/2014
1AutoantigensIBA
12/2013
1Glutamic Acid (Glutamate)FDA Link
11/2013
1CladribineFDA LinkGeneric
11/2013
1Biological Markers (Surrogate Marker)IBA
07/2013
1CB2 Cannabinoid ReceptorIBA
01/2013
1CB1 Cannabinoid Receptor (CB1 Receptor)IBA
01/2013
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2013
1Insulin (Novolin)FDA Link
01/2013
1rimonabantIBA
03/2012
1AntibodiesIBA
08/2011
1Glycoproteins (Glycoprotein)IBA
12/2010
1Non-alcoholic Fatty Liver DiseaseIBA
06/2010
1Estrogen Receptor alphaIBA
06/2010
1Interleukin-17 (Interleukin 27)IBA
01/2010
1Dermatan SulfateIBA
01/2008
1N-Acetylgalactosamine-4-Sulfatase (Arylsulfatase B)IBA
01/2008
1PD 98059IBA
11/2006
1Lovastatin (Mevacor)FDA LinkGeneric
11/2006
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
11/2006
1PropylthiouracilFDA Link
11/2006
1Terpenes (Terpenoids)IBA
11/2006
1Protein Kinases (Protein Kinase)IBA
11/2006
1Etoposide (VP 16)FDA LinkGeneric
05/2006
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
05/2006
1mouse leptin receptorIBA
02/2006
1arvanilIBA
02/2006
1Immunoglobulin A (IgA)IBA
01/2006
1Histidine DecarboxylaseIBA
01/2006